Letter from the NANS President and Annual Meeting Planning Committee
We are pleased to invite you to the NANS 22nd Annual Meeting—the world’s largest meeting in the field of neuromodulation! The 2019 meeting offers opportunities for networking with colleagues, hearing state-of-the-art lectures, and discovering the newest and up-in-coming advances in devices in our exhibit hall. With participants from more than 20 countries, NANS is the premier meeting in the world to capture the latest advances in the science and practice of neuromodulation.
We have an extensive and exciting pre-meeting educational program scheduled for Thursday, January 17, 2019. New to the NANS Annual Meeting is the Leadership Course, which will discuss best practice management, leadership, and practice strategies. The Advanced Practice Provider Course continues to grow in popularity and for its 10th year will provide an overview of neuromodulation topics. The agenda includes our popular Neuromodulation for Advanced Implantable Therapies: A Hands-On Cadaver Course for Neurosurgery Residents and Pain Fellows, combining didactic lectures and hands-on training. This year’s offerings also include the Neurology Neuromodulation Workshop, the Hands-On Cadaver Course for Engineers, and the Building a Neuromodulation Practice: Brain to Pain, Approvals, Financials, and Cases Workshop. There will be two separate Certificate of Attendance courses. The Certificate of Attendance: Advanced Neuraxial Neuromodulation course will focus on the evidence-based and appropriate utilization of implantable therapies for pain management, and the Certificate of Attendance: Peripheral Nerve Stimulation course will provide evidence-based and expert-driven instruction on peripheral nerve stimulation. There also is a full-day course to review the principles of intrathecal therapy management titled, “Simplifying IT Therapy: A Solution to the Opioid Crisis.” Once again, the Continuum of Care from Wearables to Noninvasive Neuromodulation course will be offered, which will include theoretical and hands-on practical training on the use of noninvasive neuromodulation.
The theme of the NANS 22nd Annual Meeting is “The Science Behind Successful Outcomes.” In order for healthcare professionals to harness neuromodulation’s rapid growth for their patients and to expand the appropriate use of neuromodulation therapies, not only for the treatment of pain but for other medical conditions, a detailed understanding of current literature and data sources is required. The scientific meeting developed by the Program Committee will truly assist practitioners in their need for comprehensive knowledge on neuromodulation, including historical, current, and future developments. Plenary sessions on both Friday, January 18 and Saturday, January 19, 2019, will span a diverse range of topics. Subjects covered will include the importance of trialing, the predefined acceptance of the need for neuropathic pain for a successful neuromodulation-based outcome, and proposed mechanisms of actions of new spinal cord stimulation programs. Plenary Session IV on Saturday will evaluate the current challenges surrounding the opioid epidemic in our country and the use of neuromodulation to reduce the need for opioids and possibly modulate pathways involved in addiction. Our keynote speaker, Sam Quinones, is a journalist, storyteller, former LA Times reporter, and author. His most recent book, Dreamland: The True Tale of America’s Opiate Epidemic, was the winner of the 2015 National Book Critics Circle Award for Nonfiction. Don’t miss the opportunity to hear his exciting perspective during Plenary Session IV.
Concurrent sessions on Friday and Saturday afternoon will cover crucial topics required for the advancement of neuromodulation. Both interventional and non-interventional topics will be discussed, as well as economic decision making for procedures, advocacy, healthcare policy, management of cancer pain, and rehabilitation strategies. In addition, the development of preoperative and postoperative rehab plans will be explored as a method to improve functional outcomes in patients receiving neuromodulation therapies. NANS will continue the strong collaboration with other societies to expand pain knowledge through sessions chaired by the American Academy of Pain Medicine and the American Society of Regional Anesthesia and Pain Medicine. Those sessions will discuss non-opioid analgesics as adjuncts to optimize outcomes with neuromodulation-based therapies, the influence of mental health disorders on chronic pain, emerging radiofrequency targets, and the new ketamine guidelines for chronic pain medicine. Sessions that will cover topics of high interest to engineers, scientists, and clinicians will explore bioelectric medicine, the use of neurostimulation for restoring function after injury, visceral pain, and cranial and peripheral nerve stimulation.
We look forward to welcoming you to Las Vegas for this world-class event and the largest meeting of its kind dedicated to the field of neuromodulation. In addition to excellent educational opportunities offered at this meeting, we will have multiple social events that will allow for the interactions of multiple disciplines from both faculty and attendees. We anticipate the NANS 22nd Annual Meeting to be a memorable educational and networking experience for all.